On December 28, 2023, Minim, Inc., a Delaware-incorporated company listed on the Nasdaq Capital Market under the trading symbol MINM, announced significant changes to its Board of Directors. The company expanded its Board from four to seven directors, electing Avraham Ben-Tzvi, Matthew C. McMurdo, and David E. Lazar as new directors. The expansion and appointments are part of the company's governance and strategic growth plans. Ben-Tzvi brings extensive legal expertise, having founded ABZ Law Office and served as Chief Legal Officer at Purple Biotech Ltd. McMurdo, with a background in corporate law, is the Managing Member of McMurdo Law Group, LLC, and has held various legal positions in the past. Lazar, the CEO of Titan Pharmaceuticals Inc. and...Show More

On December 28, 2023, Minim, Inc., a Delaware-incorporated company listed on the Nasdaq Capital Market under the trading symbol MINM, announced significant changes to its Board of Directors. The company expanded its Board from four to seven directors, electing Avraham Ben-Tzvi, Matthew C. McMurdo, and David E. Lazar as new directors. The expansion and appointments are part of the company's governance and strategic growth plans. Ben-Tzvi brings extensive legal expertise, having founded ABZ Law Office and served as Chief Legal Officer at Purple Biotech Ltd. McMurdo, with a background in corporate law, is the Managing Member of McMurdo Law Group, LLC, and has held various legal positions in the past. Lazar, the CEO of Titan Pharmaceuticals Inc. and Custodian Ventures LLC, offers a wealth of experience in financial and operations management. The new directors' terms will expire at Minim's 2024 annual meeting of stockholders. At the time of their election, none of the new directors were appointed to any Board committees. The Board has deemed Ben-Tzvi and McMurdo as independent directors, while Lazar, intended to be engaged as an executive officer, is not considered independent.